Key Highlights
- EvolutionaryScale launches ESM3, an advanced AI model.
- ESM3 creates a new Green Fluorescent Protein (GFP).
- Simulates 500 million years of natural evolution.
- Potential applications in drug discovery, materials science, and carbon capture.
- Open API and collaboration with AWS and NVIDIA.
Source: Business Wire
Notable Quote
- “ESM3 takes a step toward a future of biology where AI is a tool to engineer from first principles, the way we engineer structures, machines, and microchips, and write computer programs.” — Alexander Rives, Co-founder and Chief Scientist at EvolutionaryScale
SoHC's Take
The launch of ESM3 by EvolutionaryScale marks a significant milestone in the intersection of artificial intelligence and biology. By simulating 500 million years of natural evolution to create novel proteins, ESM3 has the potential to revolutionize fields ranging from drug discovery to materials science. This breakthrough not only showcases the power of AI in understanding and designing complex biological systems but also opens new avenues for research and development. The collaboration with AWS and NVIDIA further emphasizes the model’s scalability and accessibility, promising to accelerate scientific discoveries globally. The substantial seed funding underscores investor confidence in EvolutionaryScale’s vision and capabilities. This development could indeed herald a new era in biotechnology, making biology programmable in unprecedented ways.
